Novartis Corporation (JOBS) To Pay Corthera Up To $620M For Heart Drug Rights

Dow Jones -- Novartis AG (NVS) Wednesday said it is paying up to $620 million for the worldwide rights to an experimental heart drug in a deal that boosts the Swiss drug maker's portfolio of cardiovascular medicines.